50
Views
91
CrossRef citations to date
0
Altmetric
Gene Expression

DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation

, , , , , , , , , , , , & show all
Pages 9608-9620 | Received 17 Feb 2005, Accepted 14 Aug 2005, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Ixaura Medina-Medina, Paola García-Beltrán, Ignacio de la Mora-de la Mora, Jesús Oria-Hernández, Guy Millot, Robin Fahraeus, Horacio Reyes-Vivas, José G. Sampedro & Vanesa Olivares-Illana. (2016) Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions. Molecular and Cellular Biology 36:16, pages 2195-2205.
Read now
Guifen He, Yi-Wei Zhang, Jun-Ho Lee, Shelya X. Zeng, Yunyuan V. Wang, Zhijun Luo, X. Charlie Dong, Benoit Viollet, Geoffrey M. Wahl & Hua Lu. (2014) AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity. Molecular and Cellular Biology 34:2, pages 148-157.
Read now
Shaofang Wu, Lihong Chen, Andreas Becker, Ernst Schonbrunn & Jiandong Chen. (2012) Casein Kinase 1α Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding. Molecular and Cellular Biology 32:23, pages 4821-4832.
Read now
Lynn Biderman, Masha V. Poyurovsky, Yael Assia, James L. Manley & Carol Prives. (2012) MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress. Molecular and Cellular Biology 32:7, pages 1214-1225.
Read now
John P Alao. (2009) The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target. Expert Opinion on Drug Discovery 4:5, pages 495-505.
Read now
Daniele M. Gilkes, Yu Pan, Domenico Coppola, Timothy Yeatman, Gary W. Reuther & Jiandong Chen. (2008) Regulation of MDMX Expression by Mitogenic Signaling. Molecular and Cellular Biology 28:6, pages 1999-2010.
Read now
Yetao Jin, Shelya X. Zeng, Xiao-Xin Sun, Hunjoo Lee, Christine Blattner, Zhixiong Xiao & Hua Lu. (2008) MDMX Promotes Proteasomal Turnover of p21 at G1 and Early S Phases Independently of, but in Cooperation with, MDM2. Molecular and Cellular Biology 28:4, pages 1218-1229.
Read now
Giacomo Buscemi, Luigi Carlessi, Laura Zannini, Sofia Lisanti, Enrico Fontanella, Silvana Canevari & Domenico Delia. (2006) DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues. Molecular and Cellular Biology 26:21, pages 7832-7845.
Read now
Yaron Pereg, Suzanne Lam, Amina Teunisse, Sharon Biton, Erik Meulmeester, Leonid Mittelman, Giacomo Buscemi, Koji Okamoto, Yoichi Taya, Yosef Shiloh & Aart G. Jochemsen. (2006) Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage. Molecular and Cellular Biology 26:18, pages 6819-6831.
Read now

Articles from other publishers (82)

E. V. Shubnikova & N. Yu. Velts. (2023) Ototoxicity of Aminoglycosides the Modern Concepts. Antibiotics and Chemotherapy 67:11-12, pages 79-90.
Crossref
Renier C. Heijkants, Amina F. A. S. Teunisse, Danielle de Jong, Kseniya Glinkina, Hailiang Mei, Szymon M. Kielbasa, Karoly Szuhai & Aart G. Jochemsen. (2022) MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells. Cancers 14:18, pages 4482.
Crossref
Sonja Srdanović, Madita Wolter, Chi H. Trinh, Christian Ottmann, Stuart L. Warriner & Andrew J. Wilson. (2022) Understanding the interaction of 14‐3‐3 proteins with h DMX and h DM2: a structural and biophysical study . The FEBS Journal 289:17, pages 5341-5358.
Crossref
Jack D. Sanford, Jing Yang, Jing Han, Laura A. Tollini, Aiwen Jin & Yanping Zhang. (2021) MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail. BMC Molecular and Cell Biology 22:1.
Crossref
Herui Wang, Bin Li, Kulsum Asha, Ryan L. Pangilinan, Asha Thuraisamy, Harman Chopra, Susumu Rokudai, Yong Yu, Carol L. Prives & Yan Zhu. (2021) The ion channel TRPM7 regulates zinc-depletion-induced MDMX degradation. Journal of Biological Chemistry 297:5, pages 101292.
Crossref
Marta Falcicchio, Jake A. Ward, Salvador Macip & Richard G. Doveston. (2020) Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer. Cell Death Discovery 6:1.
Crossref
Ji Hoon Jung, Hyemin Lee, Shelya X Zeng & Hua Lu. (2020) RBM10, a New Regulator of p53. Cells 9:9, pages 2107.
Crossref
De-Hua Yu, Zhi-Yuan Xu, Shaowei Mo, Li Yuan, Xiang-Dong Cheng & Jiang-Jiang Qin. (2020) Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges. Frontiers in Oncology 10.
Crossref
Helge M. Magnussen, Syed F. Ahmed, Gary. J. Sibbet, Ventzislava A. Hristova, Koji Nomura, Andreas K. Hock, Lewis J. Archibald, Andrew G. Jamieson, David Fushman, Karen H. Vousden, Allan M. Weissman & Danny T. Huang. (2020) Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain. Nature Communications 11:1.
Crossref
Sue Haupt, Javier Octavio Mejía-Hernández, Reshma Vijayakumaran, Simon P Keam & Ygal Haupt. (2019) The long and the short of it: the MDM4 tail so far. Journal of Molecular Cell Biology 11:3, pages 231-244.
Crossref
KL Pennington, TY Chan, MP Torres & JL Andersen. (2018) The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions. Oncogene 37:42, pages 5587-5604.
Crossref
Shadia A. Galal, Muhammad Khattab, Samia A. Shouman, Raghda Ramadan, Omaima M. Kandil, Omnia M. Kandil, Ashraf Tabll, Yasmine S. El Abd, Reem El-Shenawy, Yasmin M. Attia, Ahmed A. El-Rashedy & Hoda I. El Diwani. (2018) Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates. European Journal of Medicinal Chemistry 146, pages 687-708.
Crossref
Loredana Cifaldi, Franco Locatelli, Emiliano Marasco, Lorenzo Moretta & Vito Pistoia. (2017) Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective. Trends in Molecular Medicine 23:12, pages 1156-1175.
Crossref
Meiyan Jiang, Takatoshi Karasawa & Peter S. Steyger. (2017) Aminoglycoside-Induced Cochleotoxicity: A Review. Frontiers in Cellular Neuroscience 11.
Crossref
Xiaolei Xie, Guangan He & Zahid H. Siddik. (2017) Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation. Molecular Cancer Research 15:3, pages 328-339.
Crossref
Nicole R. Tackmann & Yanping Zhang. (2017) Mouse modelling of the MDM2/MDMX−p53 signalling axis. Journal of Molecular Cell Biology 9:1, pages 34-44.
Crossref
X Xie, G Lozano & Z H Siddik. (2016) Heterozygous p53V172F mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53. Oncogene 35:36, pages 4798-4806.
Crossref
Jean-Christophe Marine & Aart G. Jochemsen. (2016) MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond. Cold Spring Harbor Perspectives in Medicine 6:7, pages a026237.
Crossref
X Chen, N Gohain, C Zhan, W-Y Lu, M Pazgier & W Lu. (2015) Structural basis of how stress-induced MDMX phosphorylation activates p53. Oncogene 35:15, pages 1919-1925.
Crossref
Hongwei Luo, Lauren Cowen, Guowu Yu, Wenguo Jiang & Yi Tang. (2016) SMG7 is a critical regulator of p53 stability and function in DNA damage stress response. Cell Discovery 2:1.
Crossref
David W. Meek. (2015) Regulation of the p53 response and its relationship to cancer. Biochemical Journal 469:3, pages 325-346.
Crossref
Tae-Hyung Kim, Patrick Leslie & Yanping Zhang. (2014) Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability. Oncotarget 5:4, pages 860-871.
Crossref
Andreas K. Hock & Karen H. Vousden. (2014) The role of ubiquitin modification in the regulation of p53. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:1, pages 137-149.
Crossref
Yan Zhu, Kausik Regunath, Xavier Jacq & Carol Prives. (2013) Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes & Development 27:16, pages 1739-1751.
Crossref
M. Cris Silva-Santisteban, Isaac M. Westwood, Kathy Boxall, Nathan Brown, Sam Peacock, Craig McAndrew, Elaine Barrie, Meirion Richards, Amin Mirza, Antony W. Oliver, Rosemary Burke, Swen Hoelder, Keith Jones, G. Wynne Aherne, Julian Blagg, Ian Collins, Michelle D. Garrett & Rob L. M. van Montfort. (2013) Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2. PLoS ONE 8:6, pages e65689.
Crossref
Zengxin Lu, Guohui Wan, Huarong Guo, Xinna Zhang & Xiongbin Lu. (2013) Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cellular Signalling 25:4, pages 796-804.
Crossref
X Li, D Gilkes, B Li, Q Cheng, D Pernazza, H Lawrence, N Lawrence & J Chen. (2011) Abnormal MDMX degradation in tumor cells due to ARF deficiency. Oncogene 31:32, pages 3721-3732.
Crossref
Jun-Ho Lee, Yetao Jin, Guifen He, Shelya X. Zeng, Yunyuan V. Wang, Geoffrey M. Wahl & Hua Lu. (2012) Hypoxia Activates Tumor Suppressor p53 by Inducing ATR-Chk1 Kinase Cascade-mediated Phosphorylation and Consequent 14-3-3γ Inactivation of MDMX Protein. Journal of Biological Chemistry 287:25, pages 20898-20903.
Crossref
Xinjiang Wang & Xuejun Jiang. (2012) Mdm2 and MdmX partner to regulate p53. FEBS Letters 586:10, pages 1390-1396.
Crossref
Koji Okamoto, Tatsuya Ishiguro, Yutaka Midorikawa, Hirokazu Ohata, Masashi Izumiya, Naoto Tsuchiya, Ai Sato, Hiroaki Sakai & Hitoshi Nakagama. (2012) miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. The EMBO Journal 31:7, pages 1752-1763.
Crossref
Dongsheng Pei, Yanping Zhang & Junnian Zheng. (2012) Regulation of p53: a collaboration between Mdm2 and MdmX. Oncotarget 3:3, pages 228-235.
Crossref
Tatsuya Ishiguro, Ai Sato, Hirokazu Ohata, Hiroaki Sakai, Hitoshi Nakagama & Koji Okamoto. (2012) Differential expression of nanog1 and nanogp8 in colon cancer cells. Biochemical and Biophysical Research Communications 418:2, pages 199-204.
Crossref
Muyang Li & Wei Gu. (2011) A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability. Molecular Cell 43:6, pages 1023-1032.
Crossref
Xinjiang Wang, Junru Wang & Xuejun Jiang. (2011) MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination. Journal of Biological Chemistry 286:27, pages 23725-23734.
Crossref
Chikako Ozeki, Yuichiro Sawai, Tatsuhiro Shibata, Takashi Kohno, Koji Okamoto, Jun Yokota, Fumio Tashiro, Sei-ichi Tanuma, Ryuichi Sakai, Tatsuya Kawase, Issay Kitabayashi, Yoichi Taya & Rieko Ohki. (2011) Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein. Journal of Biological Chemistry 286:20, pages 18251-18260.
Crossref
Jun-Ho Lee & Hua Lu. (2011) 14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53. Journal of Biological Chemistry 286:7, pages 5136-5142.
Crossref
Kristiaan Lenos & Aart G. Jochemsen. (2011) Functions of MDMX in the Modulation of the p53-Response. Journal of Biomedicine and Biotechnology 2011, pages 1-14.
Crossref
David L. Waning, Jason A. Lehman, Christopher N. Batuello & Lindsey D. Mayo. (2011) c-Abl Phosphorylation of Mdm2 Facilitates Mdm2-Mdmx Complex Formation. Journal of Biological Chemistry 286:1, pages 216-222.
Crossref
Jean-Christophe Marine. 2011. Cancer and Development. Cancer and Development 45 75 .
S Giglio, F Mancini, M Pellegrino, G Di Conza, E Puxeddu, A Sacchi, A Pontecorvi & F Moretti. (2010) Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity. Oncogene 29:44, pages 5935-5945.
Crossref
Shunbin Xiong, Vinod Pant, Young-Ah Suh, Carolyn S. Van Pelt, Yongxing Wang, Yasmine A. Valentin-Vega, Sean M. Post & Guillermina Lozano. (2010) Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4. Cancer Research 70:18, pages 7148-7154.
Crossref
David L. Waning, Jason A. Lehman, Christopher N. Batuello & Lindsey D. Mayo. (2010) Controlling the Mdm2-Mdmx-p53 Circuit. Pharmaceuticals 3:5, pages 1576-1593.
Crossref
Mark Wade, Yunyuan V. Wang & Geoffrey M. Wahl. (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends in Cell Biology 20:5, pages 299-309.
Crossref
David W. Meek & Ted R. Hupp. (2010) The regulation of MDM2 by multisite phosphorylation—Opportunities for molecular-based intervention to target tumours?. Seminars in Cancer Biology 20:1, pages 19-28.
Crossref
Stephen Hilton, Sebastien Naud, John J. Caldwell, Kathy Boxall, Samantha Burns, Victoria E. Anderson, Laurent Antoni, Charlotte E. Allen, Laurence H. Pearl, Antony W. Oliver, G. Wynne Aherne, Michelle D. Garrett & Ian Collins. (2010) Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2. Bioorganic & Medicinal Chemistry 18:2, pages 707-718.
Crossref
Ayeda Ayed & Theodore HuppJeremy Blaydes. 2010. p53. p53 85 99 .
Qiuju Liu, Guanjun Wang, Guihua Zhou, Yi Tan, Xiuli Wang, Wei Wei, Lucheng Liu, Wanli Xue, Wenke Feng & Lu Cai. (2009) Angiotensin II-induced p53-dependent cardiac apoptotic cell death: Its prevention by metallothionein. Toxicology Letters 191:2-3, pages 314-320.
Crossref
Xinna Zhang, Lin Lin, Huarong Guo, Jianhua Yang, Stephen N. Jones, Aart Jochemsen & Xiongbin Lu. (2009) Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response. Cancer Research 69:20, pages 7960-7968.
Crossref
Koji Okamoto, Yoichi Taya & Hitoshi Nakagama. (2009) Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Letters 583:17, pages 2710-2714.
Crossref
Chihiro Ohtsubo, Daisuke Shiokawa, Masami Kodama, Christian Gaiddon, Hitoshi Nakagama, Aart G. Jochemsen, Yoichi Taya & Koji Okamoto. (2009) Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2. Cancer Science 100:7, pages 1291-1299.
Crossref
Yunyuan V. Wang, Mathias Leblanc, Mark Wade, Aart G. Jochemsen & Geoffrey M. Wahl. (2009) Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases. Cancer Cell 16:1, pages 33-43.
Crossref
Ismael Samudio, Marina Konopleva, Bing Carter & Michael Andreeff. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 197 217 .
Scarlett Reincke, Lina Govbakh, Bettina Wilhelm, Haiyan Jin, Natalia Bogdanova, Michael Bremer, Johann H Karstens & Thilo Dörk. (2008) Mutation analysis of the MDM4gene in German breast cancer patients. BMC Cancer 8:1.
Crossref
Vanessa Lopez-Pajares, Mihee M. Kim & Zhi-Min Yuan. (2008) Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding. Journal of Biological Chemistry 283:20, pages 13707-13713.
Crossref
K Linke, P D Mace, C A Smith, D L Vaux, J Silke & C L Day. (2008) Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death & Differentiation 15:5, pages 841-848.
Crossref
S Benosman, I Gross, N Clarke, A G Jochemsen, K Okamoto, J-P Loeffler & C Gaiddon. (2007) Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis. Cell Death & Differentiation 14:12, pages 2047-2057.
Crossref
Domenico Delia & Giacomo Buscemi. 2005. The Cancer Handbook. The Cancer Handbook.
Baoli Hu, Daniele M. Gilkes & Jiandong Chen. (2007) Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding to MDM2 and MDMX. Cancer Research 67:18, pages 8810-8817.
Crossref
Yunyuan V. Wang, Mark Wade, EeTsin Wong, Yao-Cheng Li, Luo Wei Rodewald & Geoffrey M. Wahl. (2007) Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation. Proceedings of the National Academy of Sciences 104:30, pages 12365-12370.
Crossref
Martin F. Lavin & Sergei Kozlov. (2007) DNA damage-induced signalling in ataxia-telangiectasia and related syndromes. Radiotherapy and Oncology 83:3, pages 231-237.
Crossref
Rajesh K. Singh, Saravanakumar Iyappan & Martin Scheffner. (2007) Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2. Journal of Biological Chemistry 282:15, pages 10901-10907.
Crossref
Luigi Carlessi, Giacomo Buscemi, Gary Larson, Zhi Hong, Jim Zhen Wu & Domenico Delia. (2007) Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2. Molecular Cancer Therapeutics 6:3, pages 935-944.
Crossref
Jean-Christophe W. Marine, Michael A. Dyer & Aart G. Jochemsen. (2007) MDMX: from bench to bedside. Journal of Cell Science 120:3, pages 371-378.
Crossref
Stjepan Uldrijan, Willem-Jan Pannekoek & Karen H Vousden. (2006) An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. The EMBO Journal 26:1, pages 102-112.
Crossref
Franck Toledo & Geoffrey M. Wahl. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nature Reviews Cancer 6:12, pages 909-923.
Crossref
Koji Okamoto, Issay Kitabayashi & Yoichi Taya. (2006) KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochemical and Biophysical Research Communications 351:1, pages 216-222.
Crossref
Daniele M Gilkes, Lihong Chen & Jiandong Chen. (2006) MDMX regulation of p53 response to ribosomal stress. The EMBO Journal 25:23, pages 5614-5625.
Crossref
Mark Wade, Ee Tsin Wong, Mengjia Tang, Jayne M. Stommel & Geoffrey M. Wahl. (2006) Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells. Journal of Biological Chemistry 281:44, pages 33036-33044.
Crossref
Baoli Hu, Daniele M. Gilkes, Bilal Farooqi, Said M. Sebti & Jiandong Chen. (2006) MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin. Journal of Biological Chemistry 281:44, pages 33030-33035.
Crossref
J.A. JohnstonJ.F. Burrows. (2006) De-ubiquitinating enzymes: intracellular signalling and disease. Biochemical Society Transactions 34:5, pages 764-769.
Crossref
Mu-Shui Dai, Yetao Jin, Jayme R. Gallegos & Hua Lu. (2006) Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc. Neoplasia 8:8, pages 630-644.
Crossref
Yosef Shiloh. (2006) The ATM-mediated DNA-damage response: taking shape. Trends in Biochemical Sciences 31:7, pages 402-410.
Crossref
M F Lavin & N Gueven. (2006) The complexity of p53 stabilization and activation. Cell Death & Differentiation 13:6, pages 941-950.
Crossref
Mong-Hong Lee & Guillermina Lozano. (2006) Regulation of the p53-MDM2 pathway by 14-3-3 σ and other proteins. Seminars in Cancer Biology 16:3, pages 225-234.
Crossref
Guri Tzivion, Vinita Singh Gupta, Ludmila Kaplun & Vitaly Balan. (2006) 14-3-3 proteins as potential oncogenes. Seminars in Cancer Biology 16:3, pages 203-213.
Crossref
Heiko Hermeking & Anne Benzinger. (2006) 14-3-3 proteins in cell cycle regulation. Seminars in Cancer Biology 16:3, pages 183-192.
Crossref
Yulia Tabakin-Fix, Inbal Azran, Yana Schavinky-Khrapunsky, Oren Levy & Mordechai Aboud. (2006) Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis 27:4, pages 673-681.
Crossref
Franck Toledo, Kurt A. Krummel, Crystal J. Lee, Chung-Wen Liu, Luo-Wei Rodewald, Mengjia Tang & Geoffrey M. Wahl. (2006) A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 9:4, pages 273-285.
Crossref
Cynthia LeBron, Lihong Chen, Daniele M Gilkes & Jiandong Chen. (2006) Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. The EMBO Journal 25:6, pages 1196-1206.
Crossref
Yetao Jin, Mu-Shui Dai, Steven Z Lu, Yingda Xu, Zhijun Luo, Yingming Zhao & Hua Lu. (2006) 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. The EMBO Journal 25:6, pages 1207-1218.
Crossref
Chiharu Uchida, Seiichi Miwa, Tomoyasu Isobe, Kyoko Kitagawa, Takayuki Hattori, Toshiaki Oda, Hideyo Yasuda & Masatoshi Kitagawa. (2006) Effects of MdmX on Mdm2-mediated downregulation of pRB. FEBS Letters 580:7, pages 1753-1758.
Crossref
Masha V. Poyurovsky & Carol Prives. (2006) Unleashing the power of p53: lessons from mice and men: Figure 1.. Genes & Development 20:2, pages 125-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.